Nakajima, Motowo
SBI Pharmaceuticals Co., Ltd.,
Japan
2025 Rank: 153,348
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 5,674 out of 355,674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 153,348 | 158,382 |
| Total Cites | 8,972 | 10,221 |
| H-index | 52 | 55 |
| Hm-index | 18 | 19 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 5 | 6 |
| Number of Single+First Authored Papers | 19 | 19 |
| Total Cites to Single+First Authored Papers | 1,246 | 1,396 |
| Number of Single+First+Last Authored Papers | 49 | 49 |
| Total Cites to Single+First+Last Authored Papers | 2,984 | 3,280 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6,906 | 7,482 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.37 |
| Self-Citation Percentage |
12.22%
|
|
Nakajima, Motowo
SBI Pharmaceuticals Co., Ltd.,
Japan
2024 Rank: 160,095
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 5,991 out of 334,837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 160,095 | 160,366 |
| Total Cites | 8,660 | 9,894 |
| H-index | 51 | 54 |
| Hm-index | 17 | 19 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 3 | 4 |
| Number of Single+First Authored Papers | 19 | 19 |
| Total Cites to Single+First Authored Papers | 1,225 | 1,379 |
| Number of Single+First+Last Authored Papers | 50 | 50 |
| Total Cites to Single+First+Last Authored Papers | 2,941 | 3,244 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6,673 | 7,243 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.37 |
| Self-Citation Percentage |
12.47%
|
|
Nakajima, Motowo
SBI Pharmaceuticals Co., Ltd.,
Japan
2023 Rank: 135,793
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 5,174 out of 312,644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 135,793 | 140,323 |
| Total Cites | 8,404 | 9,625 |
| H-index | 51 | 53 |
| Hm-index | 17 | 18 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 5 | 6 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 1,228 | 1,380 |
| Number of Single+First+Last Authored Papers | 53 | 53 |
| Total Cites to Single+First+Last Authored Papers | 2,924 | 3,223 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6,483 | 7,059 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.36 |
| Self-Citation Percentage |
12.69%
|
|
Nakajima, Motowo
SBI Pharmaceuticals Co., Ltd.,
Japan
2022 Rank: 130,453
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 4,979 out of 293,195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 130,453 | 138,558 |
| Total Cites | 7,355 | 8,246 |
| H-index | 49 | 50 |
| Hm-index | 16 | 17 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 5 | 6 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 1,212 | 1,366 |
| Number of Single+First+Last Authored Papers | 52 | 52 |
| Total Cites to Single+First+Last Authored Papers | 2,839 | 3,134 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5,683 | 6,138 |
| Ratio of Total Citations to Distinct Citing Papers | 1.29 | 1.34 |
| Self-Citation Percentage |
10.81%
|
|
Nakajima, Motowo
The University of Tokyo,
Japan
2021 Rank: 126,480
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 4,882 out of 271,773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 126,480 | 133,229 |
| Total Cites | 7,234 | 8,102 |
| H-index | 48 | 50 |
| Hm-index | 16 | 16 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 5 | 6 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 1,203 | 1,350 |
| Number of Single+First+Last Authored Papers | 52 | 52 |
| Total Cites to Single+First+Last Authored Papers | 2,800 | 3,082 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5,593 | 6,043 |
| Ratio of Total Citations to Distinct Citing Papers | 1.29 | 1.34 |
| Self-Citation Percentage |
10.71%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.